Ad
Monday, 29 October 2018
Takeda proposes sale of Shire drug to gain European approval
Takeda Pharmaceutical Co Ltd has proposed to European regulators it could sell a Shire treatment in development due to concerns of overlap in inflammatory bowel disease treatments and its own drug Entyvio as it seeks clearance for the two companies' merger.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment